Clinical Trial

R-CMOP in Patients With Newly Diagnosed Diffuse Large B-cell Lymphoma

Recruiting Phase 1/2
View on ClinicalTrials.gov →
Summary
This is a prospective clinical study to evaluate the safety and efficacy of R-CMOP in patients with newly diagnosed diffuse large B-cell lymphoma
Trial Details
NCT Number NCT06594640
Lead Sponsor Institute of Hematology & Blood Diseases Hospital, China
Conditions Diffuse Large B-cell Lymphoma
Enrollment 108 participants
Start Date 2024-05-30
Primary Completion 2026-06-30 (estimated)
Study Completion 2027-07-30 (estimated)
Updated on ClinicalTrials.gov 2026-06-10